[HDAC2-mediated H3K27 acetylation promotes the proliferation and migration of hepatocellular carcinoma cells]. [PDF]
Tang S +5 more
europepmc +1 more source
[Deubiquitinating enzyme MINDY1 is an independent risk factor for the maintenance of stemness and poor prognosis in liver cancer cells]. [PDF]
Xia BL +5 more
europepmc +1 more source
[Strategies for liver injury caused by hepatocellular carcinoma targeted therapy]. [PDF]
Zhao SX, Liu SH, Nan YM.
europepmc +1 more source
[Factors affecting tumorigenicity in liver cancer xenografts]. [PDF]
Chai MY +6 more
europepmc +1 more source
[SLC1A5 overexpression accelerates progression of hepatocellular carcinoma by promoting M2 polarization of macrophages]. [PDF]
Zou J, Wang H, Zhang D.
europepmc +1 more source
[New progress in the technology of non-invasive diagnosis for small hepatocellular carcinoma]. [PDF]
Zhao SX, Zhang ZA, Nan YM.
europepmc +1 more source
[Chinese expert guidance on overall application of lenvatinib in hepatocellular carcinoma]. [PDF]
Yang XR +15 more
europepmc +1 more source
肝细胞癌(hepatocellular carcinoma, HCC)在全球原发性肝癌中占比超过80%,给健康带来沉重的负担,被认为是全球癌症相关死亡的第四大常见原因[1]。肝癌病例数量的不断增加不仅与人口老龄化相关,在过去20年中,与肥胖相关的脂肪性肝病的逐渐增加也加剧了肝癌病例总数的增长。值得注意的是,快速上升的非酒精性脂肪性肝病(nonalcoholic fatty liver disease, NAFLD ...
陈雨恒, 吕凌
doaj
[Establishment of a database for liver cancer ablation and its clinical research value]. [PDF]
Luo YC, Lang ML, Liang P, Yu J.
europepmc +1 more source
[Novel research horizon for liver transplantation management model in hepatocellular carcinoma based on the tumor-donor liver-recipient]. [PDF]
Xu SJ, Xu YY, Xu X.
europepmc +1 more source

